1998 AATS scientific achievement award recipient—Norman E. Shumway, MD, PhD  by Miller, D.Craig & Robbins, Robert C.
783
T he American Association for Thoracic Surgeryestablished the AATS Scientific Achievement
Award in 1994, and John W. Kirklin, MD was the first
awardee in 1995. At the 1998 AATS meeting in Boston,
President Floyd D. Loop presented the second AATS
Scientific Achievement Award to Norman E. Shumway
from Stanford University Medical School. Dr
Shumway was the president of the AATS in 1987.
Dr Shumway’s accomplishments in cardiovascular
surgery cover many parts of the discipline, but he per-
haps is most widely renowned as the father of clinical
heart transplantation. Even though he did not perform
the first successful heart transplant in a human being,
his experimental work in the laboratory going back to
1958 and his subsequent tenacity, diligence, and perse-
verance ultimately paved the way for the widespread
clinical acceptance of cardiac transplantation. Inter-
ested observers from that early era, however, can recall
that the road to eventual success was not completely
smooth. A frenzied burst of activity in cardiac trans-
plantation soon took place around the world, and
despair in the early 1970s after discouraging early clin-
ical results spawned plangent cries of protest and even
outrage in the lay press (including the cover of Life
magazine) and the medical community; all of this out-
cry nearly brought heart transplantation to a premature
demise. Quiet, persistent effort by Shumway and his
transplant team at Stanford ultimately turned this situ-
ation around.
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only the heart (“topical myocardial hypothermia”), an
advance that helped revolutionize cardiac surgery since
the early work with cardioplegia in that era by Melrose
and others was all too often associated with hearts that
stayed depolarized forever. Dr Shumway opined that
topical hypothermia “provided plenty of time for any
procedure we cared to do. From then on, we were only
limited by our imagination, rather than by the fear that
the heart would not beat again.” Applying his imagina-
tion to the problem of transposition of the great vessels,
Dr Shumway and Richard Lower investigated a tech-
nique using elective cardiac arrest whereby the heart
could be completely excised and then placed back into
the circulation with maintained viability. Early success
with this biatrial technique of cardiac replacement in
animal studies set the stage for human cardiac trans-
plantation. Over a ten-year period of animal experi-
mentation, Dr Shumway and his Stanford colleagues
perfected the technical details and systematically inves-
tigated and documented the clinical, physiologic, and
pathologic events following orthotopic cardiac auto-
transplantation and later with allograft hearts in
immunosuppressed animal hosts. On November 20,
1967, Dr Shumway proclaimed that the time was right
to proceed with human cardiac transplantation; appar-
ently, one of the foreign research fellows who previ-
ously had visited Lillehei’s unit in Minnesota when
Shumway was there was listening, and Dr Christiaan
Barnard went ahead on December 3, 1967. Dr
Shumway performed the world’s fourth human heart
transplant (if one considers Hardy’s pioneering 1964
xenograft attempt as the first) on January 6, 1968.
Based on the knowledge acquired from the persever-
ance of the Stanford program, almost 50,000 cardiac
transplants now have been performed at over 300 cen-
ters world wide. In addition, the clinical application of
combined heart-lung transplantation was introduced in
1981 by Bruce Reitz and Shumway. Single- and dou-
ble-lung transplantation, and living-related lung trans-
plants followed.
Dr Shumway’s innovative cardiac surgical research
contributions were not limited to transplantation. He
and the young surgical residents working in the labora-
tory in the early 1960s also explored using homograft
valves for cardiac valve replacement, and the early
clinical stented homografts in the aortic or mitral posi-
tion were mounted on the SAC (Shumway-Angell-
Cutter) stent. Indeed, as Donald Ross freely admits
today, Shumway and one of his residents named Cree
Pillsbury first performed pulmonary autograft aortic
valve replacement operations (or the “Ross proce-
dure”) successfully in dogs in 1964 before Ross’s
Dr Shumway comes from humble Midwest roots.
He was born on February 9, 1923, in Kalamazoo,
Michigan. He completed one year of pre-law education
at the University of Michigan before being drafted into
the army in 1943. After completing basic training at
Camp Wolters in Mineral Wells, Texas, he was sent to
the John Tarleton Agriculture Junior College in
Stephenville, Texas, for engineering training. At the
end of 6 months, he was given an army medical apti-
tude test. The final question on the examination asked:
“If you were to pass this test, would you prefer a career
in medicine or dentistry?” He marked the box marked
“medicine,” and the rest is history.
Dr Shumway thus enrolled in the Army Specialized
Training Program, which consisted of an accelerated
nine-month pre-medicine preparatory course at Baylor
University in Waco, Texas, and medical school at
Vanderbilt University, from which he graduated in
1949. Dr Shumway completed an internship and one
year of residency training in surgery at the University
of Minnesota with Dr Owen Wangensteen before again
being drafted into the air force in 1951, where he served
as a flight surgeon in Lake Charles, Louisiana. He sub-
sequently returned to the University of Minnesota to
finish his surgical residency training and begin his
research career. Those were exciting pioneering days at
the University of Minnesota, and Dr Shumway devel-
oped an intense interest in cardiac surgery during these
years of training with Dr C. Walton Lillehei and Dr F.
John Lewis. It was here in Minneapolis that he pur-
portedly came up with the aphorism, “The only hard
thing about cardiac surgery is getting to do cardiac
surgery.” Apparently, the residents in Lillehei’s unit in
those years were not allowed to get too close to the
action due to the many attending surgeons who were
scrubbed.
After 6 weeks in private practice in Santa Barbara, Dr
Shumway was invited by Dr Victor Richards to join the
Stanford University surgical faculty on February 1,
1958. The Stanford University Hospital was located in
San Francisco at that time, and Dr Frank Gerbode was
chief of Cardiovascular Surgery; this arrangement
made surgical referrals to this young, rather outspoken
cardiac surgeon from Minnesota quite sparse. Soon,
however, the new Stanford University Medical Center
was built on the main campus in Palo Alto, where Dr
Shumway started the Cardiovascular Surgery program
in January 1960.
Shortly after his arrival at Stanford in 1958, Dr
Shumway began a variety of research studies. Building
on the total body hypothermia work by F. John Lewis
at Minnesota, he devised a simple method of cooling
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intrepid first clinical application. Shumway also made
major contributions to the surgical treatment of con-
genital abnormalities in the 1960s, including a pub-
lished series of 100 children undergoing total correc-
tion of tetralogy of Fallot without operative mortality.
His aversion to condemning patients to indefinite war-
farin anticoagulation after valve replacement and his
encouragement of others led to development of the
Hancock glutaraldehyde-preserved porcine xenograft
bioprosthetic valve and the Angell-Shiley bioprosthe-
sis. In the 1960s, when some surgical authorities were
still arguing for medical treatment of patients with
acute type A aortic dissections, his indomitable “just
keep operating” spirit was responsible for the advent of
successful emergency surgical repair of the ascending
aorta in these patients. In 1970 the Stanford type A/B
classification system for dissections was put forth, and
indeed he and his colleagues even suggested that
selected patients with acute type B dissections would
benefit from early operation. A few years later in 1975,
a young Stanford faculty member, Randall B. Griepp,
introduced the clinical feasibility of replacing the entire
transverse aortic arch using profound hypothermic cir-
culatory arrest, which soon opened up new surgical vis-
tas to cardiovascular surgeons interested in challenging
thoracic aortic problems. Finally, in 1992 the success-
ful clinical introduction of endovascular stent-grafts to
treat descending thoracic aneurysms emanated from
Shumway’s department at Stanford, which was fol-
lowed by the use of stent-grafts for patients with com-
plicated acute type B aortic dissections.
In 1965 Dr Shumway was appointed chief of the
Cardiovascular Surgery Division, and in 1974 he suc-
cessfully negotiated academic and financial separation
of his small group from the Department of Surgery
when the Department of Cardiovascular Surgery was
formed. Shumway served as chairman of the
Department of Cardiovascular Surgery until 1993. He
was president of The Western Thoracic Surgical
Association in 1979, president of The American
Association for Thoracic Surgery in 1987, and was
elected honorary president for life by the International
Society of Heart and Lung Transplantation in 1980. He
has received a host of honorary degrees and fellowships
in learned societies and has been honored with many
awards, including both the Flance-Karl Award and the
Medallion for Scientific Achievement from the
American Surgical Association, the American Medical
Association Scientific Achievement Award, and the
Trustees Medal for Distinguished Achievement from
the Massachusetts General Hospital. American Heart
Association awards include the Gold Heart Award,
Glenn Lectureship, and Research Achievement Award.
He also is the recipient of the Medal of the City of
Paris, the Medawar Prize from The Transplantation
Society, the first recipient of the Texas Heart Institute
Medal, the Michael E. DeBakey Award from the
Michael E. DeBakey International Surgical Society, the
Distinguished Alumnus Award from Vanderbilt
University, and the Outstanding Achievement Award
from the University of Minnesota.
It was in the 1960s and 1970s that Shumway’s forward
thinking in terms of surgical resident education and
training earned him the enmity of many prominent sur-
geons serving on the American Board of Surgery and
American Board of Thoracic Surgery. This point of con-
tention, his shyness and humble nature (which prompted
him to minimize trips on the national speaking circuit),
and Shumway’s innate irreverence and iconoclastic spir-
it perhaps all had something to do with what was widely
construed at the time to be a maverick or outlaw school
of surgical thought. Shumway had always believed that
inquisitive young minds should not spend up to 10 years
in residency before applying their energies to their cho-
sen field of endeavor. At Stanford, he identified promis-
ing candidates early on (in their medical school years or
during internship) and then subsequently alternated them
through rotations on Cardiovascular Surgery and
General Surgery while minimizing the years spent in
General Surgery. Before 1977, many of his residents
actually finished their cardiac surgical training before
their chief resident year in General Surgery (which pro-
duced a windfall of experienced talent for the General
Surgery attendings). On the other hand, this unorthodox
approach predictably led to serious obstacles for some of
his trainees when it came time to apply for the Board
examinations. One of Shumway’s most notable resi-
dents, Edward Stinson, performed a human heart trans-
plant before he had ever seen or scrubbed on a hernia
operation. Shumway believed that young trainees should
be able to exercise their creative intellectual capabilities
earlier in their careers. It was more than 25 years later,
however, that the leading authorities in thoracic surgery
education changed their philosophy and attempted to
reduce the number of years spent doing general surgery
before entering residency training in cardiothoracic
surgery. It turned out that Shumway was just way ahead
of the times.
Throughout Dr Shumway’s long teaching career at
Stanford, he insisted that the residents actually perform
the operations as surgeon and not just assist; he has
been wont to say, “I might not be the best surgeon in
the world, but I certainly must be the best first assis-
tant.” Of all of his accomplishments, the training of an
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entire generation of accomplished cardiac surgeons
may be the one he treasures most. He always strived to
maintain an environment that was “friendly to learn-
ing” and has been known to quip, “After someone vis-
its Houston, they leave thinking that only Cooley or
DeBakey could do those cases, whereas after a visitor
leaves Stanford, they are convinced anybody could do
those cases.” Shumway is also proud of his axiom that
he never hired a junior faculty member who was not at
least as smart or as talented as he was, and in fact pre-
ferred those who were even better and smarter than he.
This policy certainly was not the norm around the
country in those early years, and similar examples are
only rarely found today. 
Dr Shumway is an intelligent, imaginative, and saga-
cious surgeon who posseses a truly pioneering spirit
and an unquenchable yearning to teach. He has been
blessed with the innate qualities that make for strong
and visionary leadership. Through his skill, dogged
dedication, and courage, Dr Norman Shumway has had
a monumental influence on the growth and develop-
ment of cardiac surgery as we know it today.
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